Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
AUTHORS
Jackson
LA ,
Campbell
JD ,
Frey
SE ,
Edwards
KM ,
Keitel
WA ,
Kotloff
KL ,
Berry
AA ,
Graham
I ,
Atmar
RL ,
Creech
CB ,
Thomsen
IP ,
Patel
SM ,
Gutierrez
AF ,
Anderson
EL ,
El Sahly
HM ,
Hill
H ,
Noah
DL ,
Bellamy
AR ,
. JAMA. 2015 7 21; 314(3). 237-46
- PMID: 26197184 [PubMed].
ABSTRACT
Human infections with the avian influenza A(H7N9) virus were first reported in China in 2013 and continue to occur. Hemagglutinin H7 administered alone is a poor immunogen necessitating evaluation of adjuvanted H7N9 vaccines.
Human infections with the avian influenza A(H7N9) virus were first reported in China in 2013 and continue to occur. Hemagglutinin H7 administered alone is a poor immunogen necessitating evaluation of adjuvanted H7N9 vaccines.
Tags: Alumni Publications 2015